ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Rheumatology

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,165Medicare Part D Prescriptions Filled, Including Refills

Rank: 3 out of 59

$1.3M Total Retail Price of All Prescriptions

Rank: 3 out of 59

666 Patients Receiving at Least One Drug in Part D
56%Patients 65 Years and Older
47% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Alabama
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 666 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

9% of this provider’s 666 patients filled at least one prescription for a schedule three drug, compared to an average of 18%.

Risky Drugs to Seniors

2% of this provider’s 3,700 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 3%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$159 was the average price of a prescription from this provider, compared to $117 among peers.

Prescriptions per Patient

12 is the average number of prescriptions (including refills) per patient, compared to an average of 12.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Alabama
HYDROXYCHLOROQUINE SULFATE 983 592 1 4
METHOTREXATE 927 555 2 1
TRAMADOL HCL 714 254 3 5
PREDNISONE 601 325 4 2
GABAPENTIN 314 113 5 7
HYDROCODONE-ACETAMINOPHEN 311 136 S3 6 3
LEFLUNOMIDE 275 164 7 11
TIZANIDINE HCL 214 51 8 15
CYMBALTA 211 80 9 12
TRAMADOL HCL-ACETAMINOPHEN 178 107 10 32
ZOLPIDEM TARTRATE 172 63 11 14
ENBREL 167 86 12 18
LYRICA 162 23 13 9
HUMIRA 144 96 14 19
CELEBREX 121 69 15 13
MELOXICAM 98 56 16 6
METHOCARBAMOL 92 38 R 17 22
CYCLOBENZAPRINE HCL 89 14 R 18 10
ATELVIA 84 65 19 106
ALLOPURINOL 79 37 20 8
TRAZODONE HCL 78 25 21 23
SAVELLA 74 24 22 89
SERTRALINE HCL 66 18 23 73
CITALOPRAM HBR 64 36 24 35
DOXYCYCLINE HYCLATE 61 35 25 84
VOLTAREN 57 24 26 36
NEXIUM 57 11 26 41
KETOROLAC TROMETHAMINE 57 0 R 26 120
AMITRIPTYLINE HCL 55 27 R 29 25
SULFASALAZINE DR 55 40 29 40
MYCOPHENOLATE MOFETIL 52 0 31 67
AZATHIOPRINE 51 22 32 33
LIDODERM 50 24 33 68
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 24, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.